zoledronic acid has been researched along with Acute Myelogenous Leukemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YX; Fan, RF; Fang, ZG; Guo, XY; Lin, DJ; Liu, LL; Liu, XF; Lu, Y; Xu, YC | 1 |
| Fukunaga, K; Ishikawa, T; Kadowaki, N; Kasai, Y; Kitawaki, T; Kondo, T; Kuzushima, K; Maekawa, R; Maekawa, T; Nieda, M; Ohmori, K; Takahara, M; Uchiyama, T | 1 |
| Hirai, M; Kadowaki, N; Kitawaki, T | 1 |
| Suzuki, K | 1 |
2 review(s) available for zoledronic acid and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
[Therapy for malignancies and inflammatory disorders by modulating human dendritic cell functions].
Topics: Cancer Vaccines; Cell- and Tissue-Based Therapy; Cells, Cultured; Dendritic Cells; Diphosphonates; Humans; Imidazoles; Immunotherapy; Inflammation; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Neoplasms; WT1 Proteins; Zoledronic Acid | 2011 |
Current therapeutic strategy for multiple myeloma.
Topics: Age Factors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Density Conservation Agents; Boronic Acids; Bortezomib; Clinical Trials as Topic; Creatinine; Cyclophosphamide; Denosumab; Dexamethasone; Diphosphonates; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Imidazoles; Immunoglobulins; Kidney; Lenalidomide; Leukemia, Myeloid, Acute; Maintenance Chemotherapy; Melphalan; Molecular Targeted Therapy; Multiple Myeloma; Neoplasms, Second Primary; Precision Medicine; Prednisolone; Pyrazines; Quality of Life; Recurrence; Remission Induction; Survival Rate; Thalidomide; Zoledronic Acid | 2013 |
1 trial(s) available for zoledronic acid and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
A phase I/IIa clinical trial of immunotherapy for elderly patients with acute myeloid leukaemia using dendritic cells co-pulsed with WT1 peptide and zoledronate.
Topics: Aged; Cancer Vaccines; Dendritic Cells; Diphosphonates; Female; Humans; Imidazoles; Leukemia, Myeloid, Acute; Male; Treatment Outcome; WT1 Proteins; Zoledronic Acid | 2011 |
1 other study(ies) available for zoledronic acid and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Zoledronic acid overcomes adriamycin resistance in acute myeloid leukemia cells by promoting apoptosis.
Topics: Antibiotics, Antineoplastic; Apoptosis; Biomarkers; Bone Density Conservation Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diphosphonates; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Imidazoles; Leukemia, Myeloid, Acute; Zoledronic Acid | 2016 |